Inflammatory Response and Survival in Pancreatic Cancer Surgery
Author Information
Author(s): Jamieson N B, Glen P, McMillan D C, McKay C J, Foulis A K, Carter R, Imrie C W
Primary Institution: University Department of Surgery, Royal Infirmary, Glasgow
Hypothesis
The study aims to examine the relationship between systemic inflammatory response and survival in patients undergoing resection for ductal adenocarcinoma of the head of the pancreas.
Conclusion
The presence of a systemic inflammatory response predicts poor outcomes in patients who have undergone potentially curative resection for ductal adenocarcinoma of the head of the pancreas.
Supporting Evidence
- Elevated C-reactive protein levels were associated with poorer survival outcomes.
- Patients with a postoperative C-reactive protein ≤10 mg/l had a median survival of 21.5 months.
- The study included patients who underwent surgery between 1993 and 2001.
Takeaway
If a patient has high levels of a certain protein after surgery for pancreatic cancer, they might not live as long as someone with lower levels.
Methodology
Patients who underwent resection had pre- and postoperative measurements of C-reactive protein and were analyzed for survival outcomes.
Limitations
This is a retrospective study and requires verification in larger prospective cohorts.
Participant Demographics
The majority of patients were under 65 years, with similar numbers of male and female patients.
Statistical Information
P-Value
P<0.001
Confidence Interval
95% CI 1.14–3.52
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website